| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/21/2011 | EP2366406A1 Method for treating psoriasis |
| 09/21/2011 | EP2366402A1 Compositions and methods for oxalate reduction |
| 09/21/2011 | EP2366401A1 Aqueous composition containing follicle-stimulating hormone |
| 09/21/2011 | EP2366400A1 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
| 09/21/2011 | EP2366399A1 Non-cytotoxic protein conjugates |
| 09/21/2011 | EP2366385A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 09/21/2011 | EP2365983A1 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
| 09/21/2011 | EP2365822A1 Snake factor v and methods of use as a procoagulant |
| 09/21/2011 | EP2365821A1 Crystalline form of linaclotide |
| 09/21/2011 | EP2365820A2 Endothelium mimicking nanomatrix |
| 09/21/2011 | EP2242479B1 Counter-pressure filtration of proteins |
| 09/21/2011 | EP2152741B1 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 09/21/2011 | EP2104510B1 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 09/21/2011 | EP2096914B1 Poly-tlr antagonist |
| 09/21/2011 | EP2076529B1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 09/21/2011 | EP1684793B1 Pharmaceutical composition comprising an insulinotropic glp-1(7-37) analogue, asp(b28)-insulin, and a surfactant |
| 09/21/2011 | EP1641823B1 Glp-1 analog fusion plroteins |
| 09/21/2011 | EP1616577B1 2-chloro-6,7-dimethoxy-N-5 [5-(1)H- indazolyl]quinazoline-4-amine, N-(1-benzyl-4-piperidinyl)-1H-indazole-5-amine dihydrochloride, 4-[2-(2,3,4,5,6-pentafluorophenyl)acryloyl]cinnamic acid and fasudil hydrochloride for use in repairing corneal perception. |
| 09/21/2011 | EP1549333B1 Compstatin analogues with improved activity |
| 09/21/2011 | EP1507547B1 Peptides for regulation of urokinase (upa) and tissue type (tpa) plasminogen activator and method of optimizing therapeutic efficacy |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1492811B1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | EP1180114B1 Use of resisitin specific antibodies in the treatment of diabetes |
| 09/21/2011 | EP1073905B1 Methods of selecting internalizing antibodies |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | EP0871474B2 Generation of human insulin |
| 09/21/2011 | EP0725791B1 Recombinant p53 adenovirus methods and compositions |
| 09/21/2011 | CN1927883B Novel cytokine zalpha11 ligand |
| 09/21/2011 | CN1919868B Chronic neuralgia related albumen and gene thereof |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN1718735B Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 09/21/2011 | CN1468089B Microparticles for delivery of the heterologous nucleic acids |
| 09/21/2011 | CN102197132A Antimicrobial agents |
| 09/21/2011 | CN102197049A Amylin derivatives |
| 09/21/2011 | CN102197048A Peptidomimetic macrocycles |
| 09/21/2011 | CN102197044A Peptide having anti-diabetic activity and use thereof |
| 09/21/2011 | CN102196815A Cancer treatments with radiation and immunocytokines |
| 09/21/2011 | CN102191305A Preparation method of hoof nail polypeptide through composite hydrolysis |
| 09/21/2011 | CN102191256A Hypha mycin gene and karyogamy gene-engineering bacteria thereof |
| 09/21/2011 | CN102191255A Preparation and application of recombinant plectasin |
| 09/21/2011 | CN102191233A Novel 10-23 deoxyribozyme analogue and application thereof |
| 09/21/2011 | CN102191207A Gene engineering bacterium of expression of soluble FGF-21 and construction method and application thereof |
| 09/21/2011 | CN102190732A PGBD-2 fusion defensin, and preparation method and application thereof |
| 09/21/2011 | CN102190721A Long-acting growth hormone |
| 09/21/2011 | CN102190720A Method for preparing human glucagon-like peptide-2 (1-35 peptide) analogue |
| 09/21/2011 | CN102190719A Polyethylene glycol modified calcitonin |
| 09/21/2011 | CN102190718A Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 09/21/2011 | CN102190713A Synthetic peptide and application thereof |
| 09/21/2011 | CN102190712A Polymyxin E composition and preparation method and application thereof |
| 09/21/2011 | CN102190711A Polymyxin E composition and preparation method and application thereof |
| 09/21/2011 | CN102190710A Polymyxin E2 composition, and preparation method and application thereof |
| 09/21/2011 | CN102190708A Barrel-shaped alpha conantokin Bt1.3 and application thereof |
| 09/21/2011 | CN102188704A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 09/21/2011 | CN102188699A Pharmaceutical composition for treating atherosclerosis, and preparation method and application thereof |
| 09/21/2011 | CN102188698A Combination of ribonuclease and artemisinin |
| 09/21/2011 | CN102188697A Application of recombinant human Rho kinase to preparation of medicaments |
| 09/21/2011 | CN102188696A Application of hair follicle cell activation factors to preparation of hair-growth products |
| 09/21/2011 | CN102188695A Ophthalmic gel composition |
| 09/21/2011 | CN102188694A Application of osteogenesis inducible factor |
| 09/21/2011 | CN102188693A Novel proteoglycan complex |
| 09/21/2011 | CN102188692A Bone peptide composition, preparation thereof, preparation method thereof and application |
| 09/21/2011 | CN102188691A Application of tachyplesin in preparing antihrombotic medicines and health-care products and preparation method thereof |
| 09/21/2011 | CN102188690A Hair growth lotion and preparation method thereof |
| 09/21/2011 | CN102188447A Preparation method for cerebroprotein hydrolysate in piracetam cerebroprotein hydrolysate tablets |
| 09/21/2011 | CN102188391A Method for preparing granulocyte-macrophage colony stimulating factor microsphere |
| 09/21/2011 | CN102188381A Preparation method of orexin-A medicament carrying liposome and medicament for treating paroxysmal sleep |
| 09/21/2011 | CN102188367A Insulin glargine injecta and preparation method thereof |
| 09/21/2011 | CN102188362A Autologous whole blood homogenate compound for reconstruction of autologous skin epidermis protective screen |
| 09/21/2011 | CN101597289B 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof |
| 09/21/2011 | CN101376675B Antimicrobial peptide |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/21/2011 | CN101257918B Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 09/21/2011 | CN101237880B Methods of treating diseases with a VEGF antagonist |
| 09/21/2011 | CN101092616B Expressing and purifying neutrophilic granule protein NGP |
| 09/21/2011 | CN101084238B Receptor selectivity lymphotoxin derivates |
| 09/21/2011 | CN101084009B Gh secretagogues and uses thereof |
| 09/21/2011 | CN101001644B Uses of spatial configuration to modulate protein function |
| 09/20/2011 | US8022252 Spatially-defined macrocyclic compounds useful for drug discovery |
| 09/20/2011 | US8022195 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair |
| 09/20/2011 | US8022191 PEG-conjugated erythropoietin |
| 09/20/2011 | US8022189 Isolated antibodies against biologically active leptin-related peptides |
| 09/20/2011 | US8022187 Recombinant blood coagulation factor IX (rFIX) mutant having factor VIII (FVIII) independent factor X (FX) activation potential |
| 09/20/2011 | US8022186 Blood plasma protein for use as carrier medical therapeutics |
| 09/20/2011 | US8022182 Truncated BAFF receptors |
| 09/20/2011 | US8022180 Method for preventing and treating Alzheimer's disease |
| 09/20/2011 | US8022179 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 09/20/2011 | US8022177 Peptides and calcium regulation in mammalian cells |
| 09/20/2011 | US8022176 FAS peptide mimetics and uses thereof |
| 09/20/2011 | US8022175 Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8022045 Inhibitors of TGF-R-signaling for treatment of CNS disorders |
| 09/20/2011 | US8022044 Compositions and methods for therapeutic use |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8022040 Hydroxyapatite-binding peptides for bone growth and inhibition |
| 09/20/2011 | US8022039 Immunogenic HER-2 variants |
| 09/20/2011 | US8022038 Composition for acceleration of type I collagen production |